Chelsea FC has released a list of players who will be competing in upcoming pre-season tournaments. Clubs in western London have revealed on their website and other social media that two of their best players are not on the travel team. Midfielders N'Golo Kante and Ruben Loftus Cheek have been confirmed to be absent from the preseason team.
The team will travel to Los Angeles, the USA for their first pre-season meeting in preparation for the next Premier League season. According to the club's statement, the duo will not travel with other members of the team due to the Covid-19 vaccination status. The remaining players passed the Covid-19 test, but Ngolo Kante and Ruben Loftus Cheek could not confirm their exact status in the Covid-19 vaccination test conducted before travelling to the United States.
What are your thoughts on this drop your comments and do you think Chelsea will take over the premier league
Content created and supplied by: Vickline (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More